These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12930415)

  • 1. The management of stage T1 grade 3 transitional cell carcinoma of the bladder.
    Evans CP; Busby JE
    BJU Int; 2003 Sep; 92(4):345-8. PubMed ID: 12930415
    [No Abstract]   [Full Text] [Related]  

  • 2. Contemporary management of stage T1 transitional cell carcinoma of the bladder.
    Sataa S; Yassine N; Ghassen HH; Imed BS; Mohamed C; Maher C; Ali H
    Tunis Med; 2005 Dec; 83 Suppl 12():87-9. PubMed ID: 16430077
    [No Abstract]   [Full Text] [Related]  

  • 3. The optimal management of T1G3 bladder cancer.
    Emiliozzi P; Pansadoro A; Pansadoro V
    BJU Int; 2008 Nov; 102(9 Pt B):1265-73. PubMed ID: 19035891
    [No Abstract]   [Full Text] [Related]  

  • 4. T1 and T2 bladder cancer: selecting optimal therapy.
    Soloway MS
    Eur Urol; 1998; 33 Suppl 4():16-7. PubMed ID: 9615202
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravesical therapy of bladder cancer: an immunotherapy success story.
    Morales A
    Int J Urol; 1996 Sep; 3(5):329-33. PubMed ID: 8886906
    [No Abstract]   [Full Text] [Related]  

  • 6. T1G3 bladder cancer--the case for TUR and BCG.
    Miller K
    Front Radiat Ther Oncol; 2002; 36():147-50. PubMed ID: 11842744
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M; Olaru V
    Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T1G3: What to do?
    Mandressi A
    Arch Ital Urol Androl; 1996 Feb; 68(1):5-7. PubMed ID: 8664922
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment and follow-up of superficial bladder cancer].
    Raitanen M
    Duodecim; 2002; 118(9):903-9. PubMed ID: 12238168
    [No Abstract]   [Full Text] [Related]  

  • 10. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update.
    Hall MC; Chang SS; Dalbagni G; Pruthi RS; Seigne JD; Skinner EC; Wolf JS; Schellhammer PF
    J Urol; 2007 Dec; 178(6):2314-30. PubMed ID: 17993339
    [No Abstract]   [Full Text] [Related]  

  • 11. Indications for early cystectomy.
    Stein JP
    Urology; 2003 Oct; 62(4):591-5. PubMed ID: 14550424
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of high-risk, non-muscle-invasive bladder cancer.
    Lerner SP
    Nat Clin Pract Urol; 2006 Aug; 3(8):398-9. PubMed ID: 16902498
    [No Abstract]   [Full Text] [Related]  

  • 13. Current problems and needs in the treatment of pT1 G3 bladder carcinoma.
    Martínez Portillo FJ; Alken P
    Int Urol Nephrol; 2002; 33(1):29-40. PubMed ID: 12090335
    [No Abstract]   [Full Text] [Related]  

  • 14. Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin.
    Brake M; Loertzer H; Horsch R; Keller H
    J Urol; 2000 Jun; 163(6):1697-701. PubMed ID: 10799163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [BCG therapy of superficial tumors of the bladder].
    Prapotnich D
    Bull Cancer; 1998 Feb; 85(2):135-9. PubMed ID: 9752330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCG in management of transitional cell carcinoma invasive to prostate.
    Siami P; Chinn S; Clayton M; Ray V; Rubenstein M; Guinan P
    Urology; 1989 Dec; 34(6):381-2. PubMed ID: 2595884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term results.
    Pansadoro V; Emiliozzi P; Defidio L; Donadio D; Florio A; Maurelli S; Lauretti S; Sternberg CN
    J Urol; 1995 Dec; 154(6):2054-8. PubMed ID: 7500457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new staging system for transitional cell carcinoma involvement of the prostate and reconfirmation studies of intravesical therapy for superficial bladder cancer.
    Hudson MR
    J Urol; 1996 Sep; 156(3):972-4. PubMed ID: 8709376
    [No Abstract]   [Full Text] [Related]  

  • 19. [pT1G3 bladder carcinoma: our experience].
    Dell'Orto P; Trinchieri A; D'Addezio F; Bernardini P; Mangiarotti B; Del Nero A; Pisani E
    Arch Ital Urol Androl; 1996 Feb; 68(1):9-11. PubMed ID: 8664927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-muscle-invasive high-grade bladder cancer].
    Gakis G; Stenzl A; Horn T; Gschwend JE; Otto W; Burger M
    Urologe A; 2015 Apr; 54(4):491-8. PubMed ID: 25802103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.